STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare CMO executes RSU-withholding sales totaling 85,034 shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare (ALHC) Chief Medical Officer Hyong (Ken) Kim reported two non-discretionary stock sales tied to restricted stock unit vesting and a pre-existing trading plan. On 10/08/2025 Mr. Kim sold 33,655 shares at $17.29 to cover tax withholding, leaving 413,712 shares prior to the second sale. On 10/09/2025 he sold 51,379 shares at $17.5713, leaving 362,333 shares beneficially owned after the transactions. The Form 4 notes a Rule 10b5-1 trading plan adopted on 03/14/2025, and the filings state these sales were not discretionary trades but routine tax-withholding dispositions tied to RSU vesting.

Positive

  • Sales tied to RSU tax withholding indicate routine administrative disposition rather than discretionary selling
  • Transactions executed under a Rule 10b5-1 plan (adopted 03/14/2025) provide procedural defensibility

Negative

  • Total reported reduction of 85,034 shares reduced beneficial holdings to 362,333 shares after the trades

Insights

Insider sold shares for tax withholding under a 10b5-1 plan; transactions appear procedural, not opportunistic.

These reports show the Chief Medical Officer executed two non-derivative sales totaling 85,034 shares on 10/08/2025 and 10/09/2025 at prices of $17.29 and $17.5713. The filing explicitly states the 33,655‑share sale was to cover tax withholding from RSU vesting and that the plan date is 03/14/2025.

The key dependency is the stated nature of the transactions: if they were executed solely to satisfy withholding, they carry limited governance signal. Watch short-term insider ownership levels and any future voluntary sales for potential shifts in insider conviction over the next 3–12 months.

Insider Kim Hyong
Role Chief Medical Officer
Sold 85,034 shs ($1.48M)
Type Security Shares Price Value
Sale Common Stock 51,379 $17.5713 $903K
Sale Common Stock 33,655 $17.29 $582K
Holdings After Transaction: Common Stock — 362,333 shares (Direct)
Footnotes (1)
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Date of Rule 10b5-1 plan adoption: 03/14/2025
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kim Hyong
(Last) (First) (Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CA 92868
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/08/2025 S 33,655(1) D $17.29 413,712 D
Common Stock 10/09/2025 S(2) 51,379 D $17.5713 362,333 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. Date of Rule 10b5-1 plan adoption: 03/14/2025
Remarks:
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did the ALHC Form 4 filed for Hyong (Ken) Kim report?

The filing reports two non-discretionary sales of common stock: 33,655 shares on 10/08/2025 at $17.29 and 51,379 shares on 10/09/2025 at $17.5713.

Why were the ALHC shares sold by the Chief Medical Officer?

The Form 4 explains the 33,655-share sale was to cover tax withholding from RSU vesting; the filing notes the trades were not discretionary.

Was the insider trading linked to a 10b5-1 plan for ALHC (symbol: ALHC)?

Yes. The filing discloses a Rule 10b5-1 plan adoption date of 03/14/2025.

How many ALHC shares does Hyong (Ken) Kim beneficially own after these transactions?

After the reported sales, the filing shows beneficial ownership of 362,333 shares.

Do these Form 4 sales reflect discretionary trading by the insider?

No. The filing states at least one transaction was to cover tax withholding from RSU vesting and that the sales do not represent discretionary trades.